Hydrogel cap aims to ease pain after nerve surgery

NCT ID NCT07246980

Recruiting now Symptom relief Sponsor: Tulavi Therapeutics,Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study is tracking 1,000 people who have received or will receive the Allay Hydrogel Cap, a gel device placed during nerve surgery to protect the nerve ending. Researchers are collecting real-world data on pain levels, medication use, and complications to see how safe and helpful the cap is. The goal is to better understand if this cap can reduce pain and improve recovery after procedures like amputation or neuroma removal.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Allay Hydrogel Cap (implantable hydrogel device)
What this could lead to: If successful, this could confirm that the cap safely reduces pain and complications after nerve surgery, offering a reliable option for patients.
What could go wrong: This is an observational registry, not a controlled trial, so results may be less definitive. The device is already in use, and the study mainly tracks outcomes rather than proving effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL NERVE INJURIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Peripheral Nerve Injuries traumatic neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL NERVE INJURIES

Contacts and locations

Locations

Complete Foot and Ankle Care of North Texas, PA
RECRUITING

Denton, Texas, 33702, United States
Florida Orthopedic Institute
RECRUITING

St. Petersburg, Florida, 33702, United States
Orlando Health
RECRUITING

Orlando, Florida, 32806, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.